Largest pharmaceuticals by total assets

Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.

Pfizer leads the 61 pharmaceuticals ranked by total assets, at €189.7B, ahead of Johnson & Johnson (€181.6B) and Sanofi (€128.2B). Figures as of 18 Nov 2026, 15:42 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
61
First
Pfizer€189.7B
Median
€3.2B
Combined market value
€4.63T
Countries
10

Market values as of .

Largest pharmaceuticals by total assets
#CompanyTotal assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1PfizerPFE · Health Care€189.7B€146.2B€25.65 1.14% down 14% up United States
2Johnson & JohnsonJNJ · Health Care€181.6B€603.4B€250.67 1.32% down 38% up United States
3SanofiSNY · Health Care€128.2B€103.5B€43.10 0.50% down 4% down France
4Merck & CoMRK · Health Care€124.8B€313.9B€127.35 2.55% down 51% up United States
5AbbVieABBV · Health Care€122.1B€463.1B€261.97 1.85% down 26% up United States
6AstraZenecaAZN · Health Care€104B€252.8B€163.01 1.88% down 2% up United Kingdom
7Eli LillyLLY · Health Care€102.5B€1.13T€1,269.58 1.60% down 35% up United States
8NovartisNVS · Health Care€101.1B€269.2B€142.54 1.73% down 25% up Switzerland
9Takeda PharmaceuticalTAK · Health Care€88.5B€62.2B€19.48 1.22% down 54% up Japan
10Bristol-Myers SquibbBMY · Health Care€82.1B€111.5B€54.54 2.48% down 34% up United States
11Abbott LaboratoriesABT · Health Care€79B€164.5B€94.96 0.51% down 17% down United States
12GSKGSK · Health Care€73.9B€89.2B€44.52 0.81% down 6% up United Kingdom
13Novo NordiskNVO · Health Care€73.4B€158.8B€36.03 2.89% down 17% down Denmark
14Teva Pharmaceutical IndustriesTEVA · Health Care€37.1B€44.9B€38.52 0.84% down 74% up Israel
15Regeneron PharmaceuticalsREGN · Health Care€37B€90B€870.42 0.30% down 36% up United States
16ViatrisVTRS · Health Care€33.9B€21.5B€18.77 0.68% up 96% up United States
17Vertex PharmaceuticalsVRTX · Health Care€23.4B€123.2B€485.92 0.21% down 27% up United States
18GrifolsGRFS · Health Care€19.9B€5.3B€7.76 1.39% down 1% up Spain
19Royalty PharmaRPRX · Health Care€17.9B€35.8B€62.29 0.50% down 78% up United States
20ZoetisZTS · Health Care€14.1B€31B€76.27 0.23% up 29% down United States
21Elanco Animal HealthELAN · Health Care€12.2B€12B€23.95 1.62% up 20% up United States
22GenmabGMAB · Health Care€11.7B€28.8B€46.72 1.35% down 70% up Denmark
23Jazz PharmaceuticalsJAZZ · Health Care€10.6B€14.2B€221.18 0.81% up 37% up Ireland
24BeOne MedicinesONC · Health Care€7.5B€42B€367.79 2.36% down 17% up Switzerland
25United TherapeuticsUTHR · Health Care€7.2B€22.1B€519.58 2.41% down 23% up United States
26BioMarin PharmaceuticalBMRN · Health Care€6.9B€10.5B€54.41 2.02% up 11% up United States
27Dr. Reddy's LaboratoriesRDY · Health Care€5.6B€11.4B€13.62 1.05% up 5% up India
28Roivant SciencesROIV · Health Care€5.2B€25.5B€35.20 0.25% down 90% up United Kingdom
29Alnylam PharmaceuticalsALNY · Health Care€4.5B€18.7B€139.49 2.21% down 66% down United States
30Amneal PharmaceuticalsAMRX · Health Care€3.4B€6.8B€19.55 1.56% up 83% up United States
31Ionis PharmaceuticalsIONS · Health Care€3.2B€4.1B€24.67 0.37% up 64% down United States
32PTC TherapeuticsPTCT · Health Care€2.6B€4.6B€54.91 0.20% down 20% down United States
33AlkermesALKS · Health Care€2.3B€7.1B€42.18 1.83% up 58% up Ireland
34InsmedINSM · Health Care€2.1B€23.8B€108.68 2.16% down 40% down United States
35Legend BiotechLEGN · Health Care€1.6B€2.8B€14.63 0.37% down 42% down United States
36Ligand PharmaceuticalsLGND · Health Care€1.4B€5.4B€268.64 0.31% up 43% up United States
37Ascendis PharmaASND · Health Care€1.3B€16.1B€246.13 0.43% down 28% up Denmark
38CytokineticsCYTK · Health Care€1.3B€6.6B€47.07 0.01% down 20% down United States
39Arrowhead PharmaceuticalsARWR · Health Care€1.3B€5.5B€39.22 0.08% up 10% up United States
40Madrigal PharmaceuticalsMDGL · Health Care€1.1B€8.8B€376.88 2.02% down 24% down United States
41TG TherapeuticsTGTX · Health Care€969.2M€8.7B€57.67 0.89% up 107% up United States
42Praxis Precision MedicinesPRAX · Health Care€854.9M€7.8B€278.10 0.01% up 61% up United States
43Cogent BiosciencesCOGT · Health Care€854.6M€4.5B€25.74 1.38% up 20% down United States
44BridgeBio PharmaBBIO · Health Care€853.2M€13.7B€70.40 0.56% up 17% up United States
45Mirum PharmaceuticalsMIRM · Health Care€768.2M€5.4B€83.06 0.90% down 31% up United States
46Corcept TherapeuticsCORT · Health Care€762.6M€6.7B€61.44 3.81% down 8% down United States
47Belite BioBLTE · Health Care€711.5M€5.9B€144.58 0.57% up 31% up United States
48Spyre TherapeuticsSYRE · Health Care€708.9M€8.2B€85.88 0.43% up 286% up United States
49Kiniksa Pharmaceuticals InternationalKNSA · Health Care€696.1M€6.8B€87.05 0.41% up 126% up United Kingdom
50Summit TherapeuticsSMMT · Health Care€684.7M€7.7B€9.61 1.22% down 36% down United States
51Axsome TherapeuticsAXSM · Health Care€628.8M€6.3B€120.69 2.60% down 7% down United States
52Protagonist TherapeuticsPTGX · Health Care€609.1M€7.4B€113.47 0.14% down 46% up United States
53ABIVAXABVX · Health Care€591M€6.7B€76.16 1.77% up 27% down France
54Travere TherapeuticsTVTX · Health Care€551.6M€4.4B€45.48 2.35% down 44% up United States
55Edgewise TherapeuticsEWTX · Health Care€503.7M€4.1B€37.12 3.13% down 88% up United States
56Dianthus TherapeuticsDNTH · Health Care€483.9M€4.4B€78.50 0.99% down 113% up United States
57Oruka TherapeuticsORKA · Health Care€445.4M€6B€87.88 0.09% up 241% up United States
58Rhythm PharmaceuticalsRYTM · Health Care€437.7M€7.4B€106.14 0.15% down 13% up United States
59Definium TherapeuticsDFTX · Health Care€401.2M€3.6B€25.98 3.00% down 169% up United States
60ErascaERAS · Health Care€361.1M€4.2B€11.98 5.40% down 403% up United States
61VeradermicsMANE · Health Care€139.1M€4.7B€112.52 1.74% down 233% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.9115 EUR).

Questions and answers

Which pharmaceuticals rank first by total assets?

Pfizer (€189.7B), Johnson & Johnson (€181.6B) and Sanofi (€128.2B) are the top three of the 61 pharmaceuticals ranked by total assets as of 18 Nov 2026, 15:42 UTC.

How many pharmaceuticals are in this ranking?

61 are ranked by total assets.

What are these pharmaceuticals worth together?

The 61 pharmaceuticals ranked by total assets have a combined market value of €4.63T as of 18 Nov 2026, 15:42 UTC.

What does ranking by total assets measure?

Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets

Underlying data: Yahoo Finance; SEC EDGAR.